Spontaneous recanalization of a completely occluded saphenous vein graft two months following acute myocardial infarction with persistent one year patency

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 1, 2009, Pages 101-105

  Hu, Patrick P ^a   Peterson, Kirk L ^a   Tsimikas, Sotirios ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angioplasty; Drug eluting stent; Fibrinolysis; Myocardial infarction; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; CLOPIDOGREL; EPTIFIBATIDE; EZETIMIBE PLUS SIMVASTATIN; GLYCERYL TRINITRATE; HEPARIN; ISOSORBIDE MONONITRATE; METOPROLOL; RAMIPRIL; TRIACYLGLYCEROL; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ANAMNESIS; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; GRAFT OCCLUSION; HEART VENTRICULOGRAPHY; HUMAN; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; ST SEGMENT ELEVATION; T WAVE INVERSION; THORAX PAIN; TREATMENT DURATION; VASCULAR PATENCY;

AGED; ASPIRIN; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MYOCARDIAL INFARCTION; SAPHENOUS VEIN;

EID: 67449106318     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0339-x     Document Type: Article

References (19)

1. Baim DS (2003) Percutaneous treatment of saphenous vein graft disease: the ongoing challenge. J Am Coll Cardiol 42:1370-1372. doi: 10.1016/ s0735-1097(03)01039-8
2. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR (1996) Coronary artery bypass grafting fate and angiographic follow up of 5065 grafts related to survival and reoperation in 1388 patients in 25 years. J Am Coll Cardiol 28:616-626. doi: 10.1016/0735-1097(96)00206-9
3. Brooks MM, Alderman EL, Bates E, Bourassa M, Califf RM, Chaitman BR, Detre KM, Feit F, Frye RL, Gibbons RJ, Hardison RM, Hlatky MA, Holmes DR, Jacobs AK, Kelsey SF, Krauland M, Rogers WJ, Hartzell VS, Schwartz L, Sutton-Krauland K, Rogers WJ, Schaff HV, Schwartz L, Sutton-Tyrrell K, William DO, Whitlow PK (2007) The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49:1600-1606. doi: 10.1016/j.jacc.2006.11.048
4. Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM, Brennan DM, Ellis SG, Topol EJ (2002) Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation 106:3063-3067. doi: 10.1161/01.cir.0000041250.89627.a9
5. Reiner JS, Lundergan CF, Kopecky SL (1996) Ineffectiveness of thrombolysis for acute MI following vein graft occlusion (abstr). Circulation 94(Suppl I):I570
6. Al Suwaidi J, Velianou JL, Berger PB, Mathew V, Garratt KN, Reeder GS, Grill DE, Holmes DR Jr (2001) Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J 142:452-459. doi: 10.1067/ mhj.2001.117319
7. Stone GW, Brodie BR, Griffin JJ, Grines L, Boura J, O'Neill WW, Grines CL (2000) Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infraction, PAMI-2 Trial. J Am Coll Cardiol 35:605-611. doi: 10.1016/s0735-1097(99)00605-1
8. Labinaz M, Sketch MH, Ellis SG, Abramowitz BM, Stebbins AL, Peiper KS, Holmes DR Jr, Califf RM, Topol EJ (2001) Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. Am Heart J 141:469-477. doi: 10.1067/mhj.2001.112779
9. Beygui F, Montalescot G (2005) The use of GP IIb/IIIa inhibitor into new perspectives: Pre-catheterization laboratory administration. Eur Heart J Suppl 7:I10-I14. doi: 10.1093/eurheartj/sui062
10. Angiolillo DJ, Capranzano P (2008) Pharmacology of emerging novel platelet inhibitors. Am Heart J 156:S10-S15. doi: 10.1016/ j.ahj.2008.06.004
11. Dangoisse V, Colizza F (1990) Spontaneous thrombolysis in a suboccluded saphenous vein graft. Am Heart J 119:394-396. doi: 10.1016/ S0002-8703(05)80034-1
12. Shah RA, Khanal S, Kugelmass A (2006) Spontaneous late thrombolysis of an occluded saphenous vein graft subsequent to acute myocardial infarction treated with percutaneous coronary intervention to the native culprit vessel. J Interv Cardiol 19:178-182. doi: 10.1111/ j.1540-8183.2006.00129.x
13. Rimar D, Crystal E, Battler A, Gottlieb S, Friemark D, Hod H, Boyko V, Mandelzweig L, Behar S, Leor J (2002) Improved prognosis of patients with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart 88:352-356. doi: 10.1136/heart.88.4.352
14. Gharacholou SM, Becker RC (2009) Hemostasis and thrombosis in older adults. J Thromb Thrombolysis 27:249-251. doi: 10.1007/s11239-009-0308-4
15. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17, 187 cases of suspected acute myocardial infarction ISIS-2. Lancet 332:349-360. doi: 10.1016/ S0140-6736(88)92833-4
16. Jansson JH, Olofsson BO, Nilsson TK (1993) Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: A 7-year follow-up. Circulation 88:2030-2034
17. Hamsten A, Wiman B, de Faire U, Blombäck M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563
18. Osterlund B, Andersson B, Haggmark S, Jern C, Johansson G, Seeman-Lodding, Biber B (2002) Myocardial ischemia induces coronary t-PA release in the pig. Acta Anaesthesiol Scand 46:271-278. doi: 10.1034/ j.1399-6576.2002.t01-1-460308
19. Doggrell SA (2005) CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction. Expert Opin Pharmacother 6:1761-1764. doi: 10.1517/14656566.6.10.1761